TIM‐3 interacts with its soluble ligand, galectin‐9, which is highly expressed by antigen‐presenting cells (APCs) in HCC, to inhibit anti‐tumour immunity by mediating inducing T‐cell exhaustion and senescence. The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.